Investigating Pfizer's Reporting on Vaccine Adverse Effects

This chapter delves into the discrepancies between Pfizer's reporting of a girl's severe neurological issues after receiving a vaccine in a clinical trial and the actual severity of her condition. It discusses the response from the FDA, concerns about accountability and transparency in investigating vaccine adverse effects, conflicts of interest within the FDA and its advisory committees, and the importance of transparency and independence in reviewing vaccine safety data.